ZTEK Stock Overview Engages in the research and development of graphene and related nanomaterials in Canada. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Zentek Historical stock prices Current Share Price CA$1.17 52 Week High CA$1.34 52 Week Low CA$0.50 Beta 1.17 1 Month Change -0.86% 3 Month Change -7.89% 1 Year Change -5.66% 3 Year Change -61.39% 5 Year Change 197.05% Change since IPO 262.17%
Recent News & Updates
Third quarter 2025 earnings released: CA$0.025 loss per share (vs CA$0.027 loss in 3Q 2024) Feb 13
Zentek Ltd. Provides Update on ZenGUARD Enhanced Air Filters for the Canadian Market Jan 17
New minor risk - Market cap size Dec 20
Zentek Ltd. Announces its Decision That its ZenGUARD Enhanced Air Filters Will Be Added Under the Existing Medical Device Establishment Licence Nov 27
New major risk - Financial position Nov 15
Zentek Ltd. Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters Nov 02 See more updates
Third quarter 2025 earnings released: CA$0.025 loss per share (vs CA$0.027 loss in 3Q 2024) Feb 13
Zentek Ltd. Provides Update on ZenGUARD Enhanced Air Filters for the Canadian Market Jan 17
New minor risk - Market cap size Dec 20
Zentek Ltd. Announces its Decision That its ZenGUARD Enhanced Air Filters Will Be Added Under the Existing Medical Device Establishment Licence Nov 27
New major risk - Financial position Nov 15
Zentek Ltd. Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters Nov 02
Zentek Ltd. Provides Market Update on ZenGUARD Antimicrobial Surgical Masks Oct 17
New minor risk - Shareholder dilution Aug 22 Zentek Ltd. announced that it has received CAD 3.06995 million in funding Aug 20
Zentek Ltd. announced that it expects to receive CAD 3 million in funding
Full year 2024 earnings released: CA$0.12 loss per share (vs CA$0.14 loss in FY 2023) Jun 28
Zentek Ltd. Announces Board and Management Changes May 06
Zentek Ltd. Provides ZenGUARD Business Update Apr 27 Zentek Ltd.'s Subsidiary Triera Biosciences Ltd. Completes Testing of Its C19HBA Aptamer as Potential Therapeutic Jan 31
Zentek Ltd. Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters Jan 22
Zentek Ltd. Announces Board Changes Jan 19
New minor risk - Share price stability Jan 16
Zentek Ltd. Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant Nov 30 Zentek Ltd. announced a financing transaction Nov 22
Zentek Ltd. Completes Return on Investment Analysis for Canadian Healthcare System Oct 18 Zentek Ltd. Elects John Snisarenko as Director
Zentek Ltd Announces the Successful Results of A Recent Study Conducted by ParticleOne Sep 12
Zentek Ltd. Announces the Results of Study Comparing the Viral Filtration Efficiency of Its Zenguard-Enhanced MERV 9 Filters with an Uncoated MERV 9 Filter Sep 07
First quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.051 loss in 1Q 2023) Aug 13 Zentek Ltd., Annual General Meeting, Oct 05, 2023 Aug 01
Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential Jul 22
Zentek Ltd. Announces Updates to Senior Management Team Jul 14
Zentek Receives a Deficiency Letter from Nasdaq Stock Market LLC Jul 01
Full year 2023 earnings released: CA$0.14 loss per share (vs CA$0.13 loss in FY 2022) Jul 01
Zentek Ltd. Appoints Lisa Sim to the Board of Directors Jun 02
Albany Graphite Corp. acquired Albany Graphite Project from Zentek Ltd. for approximately CAD 136 million. May 25
Zentek Ltd. Introduces A Novel Corrosion Protection Technology: ZenARMOR Feb 09
Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating Feb 08
Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating Feb 07
Zentek Ltd. Announces Appointment of Mitch Swergold as Director of Investor Relations Jan 13
Zentek Ltd Announces Successful Phase 2 Results of HVAC Testing Dec 17
Less than half of directors are independent Nov 16
Zentek Ltd. Provides Update on Battery Technology Development Oct 29
Zentek Provides Update on Icephobic Coating Technology Sep 20
Zentek Ltd. Provides Update on HVAC Testing Sep 16
Zentek enters manufacturing and supply agreement with Viva Healthcare Packaging Sep 07
Zentek Ltd., Annual General Meeting, Sep 29, 2022 Jul 30
Zentek Files Provisional Patent on the Use of ZenGUARD as an Anti-Inflammatory Agent Jul 19
Zentek Ltd. Appoints Ilse Treurnicht to Its Board of Directors Jul 06
Zentek Ltd. Provides Update on ZenGUARDTM Patent Status Jun 07 Zentek Ltd. Announces Chief Financial Officer Changes
Less than half of directors are independent Apr 28
Zentek Ltd. Announces Start of Phase Two Testing of Zenguardtm -Coated Filters Apr 12
Zentek Ltd. Announces Filing of Provisional Patent for Fire-Retardant Additive Mar 29
Less than half of directors are independent Mar 23 Zentek Ltd. Appoints Ravi Kaza to Its Advisory Board Mar 10
Zentek Ltd. Announces Development of Graphene-Wrapped Silicon Anodes Feb 19
Zentek Ltd. announced that it has received CAD 10.009022 million in funding Jan 06
Zentek Ltd. announced that it expects to receive CAD 10.009022 million in funding Dec 24
Zen Graphene Solutions and Trebor Rx Announce Health Canada Approval for ZENGuardTM Mask Sep 24
ZEN Graphene Solutions Ltd. Develops Stable Diesel Fuel Additive Jun 02
ZEN Graphene Solutions Ltd. announced that it has received CAD 4.337998 million in funding Apr 10
ZEN Graphene Solutions Ltd. announced that it expects to receive CAD 2 million in funding Mar 26
ZEN Graphene Solutions Ltd. Announces Successful Testing of its Graphene Compound Against Antimicrobial-Resistant Bacteria Mar 18 ZEN Graphene Solutions and Trebor Rx Corp. Announce Successful Health Canada Testing Requirements of Surgical Masks
Zen Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound Feb 05
ZEN Graphene Solutions Ltd. Announces Management Changes Jan 22
Zen Graphene Solutions Ltd. Provides Update on Cytotoxicity Testing of Graphene-Based Compound and Effectiveness of Graphene-Based Coating Dec 30
ZEN Graphene Solutions Ltd. Appoints Gregory Fenton as New Chief Executive Officer Dec 10
Zen Graphene Solutions Ltd. Announces New Research Collaboration Agreement on Carbon Aerogels with Deutsches Zentrum fuer Luft- und Raumfahrt e. V Oct 16
ZEN Graphene Solutions Ltd. Solutions Signs 2 Year Extension with Chemisar Laboratories Inc Oct 11
Zen Graphene Solutions and Guelph University Researchers File Patent on Graphene Oxide Production Method Oct 05
ZEN Graphene Solutions Ltd. Develops Novel Graphene-Based Virucidal Ink with 99% Effectiveness Against COVID-19 Sep 24
ZEN Graphene Solutions Ltd. announced that it has received CAD 2.05 million in funding Jul 08 Shareholder Returns ZTEK US Medical Equipment US Market 7D 5.4% 0.7% 1.5% 1Y -5.7% 13.0% 22.4%
See full shareholder returns
Return vs Market: ZTEK underperformed the US Market which returned 22.4% over the past year.
Price Volatility Is ZTEK's price volatile compared to industry and market? ZTEK volatility ZTEK Average Weekly Movement 9.9% Medical Equipment Industry Average Movement 7.9% Market Average Movement 5.9% 10% most volatile stocks in US Market 18.0% 10% least volatile stocks in US Market 3.0%
Stable Share Price: ZTEK has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ZTEK's weekly volatility (10%) has been stable over the past year.
About the Company Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis.
Show more Zentek Ltd. Fundamentals Summary How do Zentek's earnings and revenue compare to its market cap? ZTEK fundamental statistics Market cap US$119.20m Earnings (TTM ) -US$7.52m Revenue (TTM ) US$45.62k
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) ZTEK income statement (TTM ) Revenue CA$64.66k Cost of Revenue CA$585.98k Gross Profit -CA$521.32k Other Expenses CA$10.14m Earnings -CA$10.66m
Last Reported Earnings
Dec 31, 2024
Earnings per share (EPS) -0.10 Gross Margin -806.30% Net Profit Margin -16,483.58% Debt/Equity Ratio 2.4%
How did ZTEK perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/16 11:26 End of Day Share Price 2025/02/14 00:00 Earnings 2024/12/31 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Zentek Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Troy Jensen Lake Street Capital Markets, LLC Joseph Reagor Roth Capital Partners
